These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 1545441)
1. Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity. See WA; Xia Q J Natl Cancer Inst; 1992 Apr; 84(7):510-5. PubMed ID: 1545441 [TBL] [Abstract][Full Text] [Related]
2. Regional chemotherapy using continuous intravesical infusion doxorubicin for the treatment of muscle invasive transitional cell bladder carcinoma in a rat model. See WA; Xia Q; McDermott T; Williams RD J Urol; 1991 Oct; 146(4):1147-52. PubMed ID: 1895443 [TBL] [Abstract][Full Text] [Related]
3. Absorption of epi-doxorubicin after intravesical administration in patients with in situ transitional cell carcinoma of the bladder. Mross K; Maessen P; van der Vijgh WJ; Bogdanowicz JF; Kurth KH; Pinedo HM Eur J Cancer Clin Oncol; 1987 May; 23(5):505-8. PubMed ID: 3477456 [TBL] [Abstract][Full Text] [Related]
4. DPPG Brummelhuis ISG; Simons M; Lindner LH; Kort S; de Jong S; Hossann M; Witjes JA; Oosterwijk E Int J Hyperthermia; 2021; 38(1):1415-1424. PubMed ID: 34581259 [TBL] [Abstract][Full Text] [Related]
5. DPPG van Valenberg FJP; Brummelhuis ISG; Lindner LH; Kuhnle F; Wedmann B; Schweizer P; Hossann M; Witjes JA; Oosterwijk E Int J Nanomedicine; 2021; 16():75-88. PubMed ID: 33447028 [TBL] [Abstract][Full Text] [Related]
6. Intravesical chemotherapy: combination with dimethyl sulfoxide does not enhance cytotoxicity in vitro. Walker L; Walker MC; Parris CN; Masters JR Urol Res; 1988; 16(4):329-31. PubMed ID: 3176208 [TBL] [Abstract][Full Text] [Related]
7. Comparative investigation on use of (2''R)-4'-O-tetrahydropyranyl-adriamycin and adriamycin as intravesical chemotherapy for superficial bladder tumors. Akaza H; Niijima T; Hisamatsu T; Fujigaki M Urology; 1988 Aug; 32(2):141-5. PubMed ID: 3400139 [TBL] [Abstract][Full Text] [Related]
8. Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer. Kamat AM; DeHaven JI; Lamm DL Urology; 1999 Jul; 54(1):56-61. PubMed ID: 10414727 [TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model. Falke J; Hulsbergen-van de Kaa CA; Maj R; Oosterwijk E; Witjes JA World J Urol; 2018 Nov; 36(11):1719-1725. PubMed ID: 29767328 [TBL] [Abstract][Full Text] [Related]
11. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation. Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888 [TBL] [Abstract][Full Text] [Related]
12. Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel. Chen D; Song D; Wientjes MG; Au JL Clin Cancer Res; 2003 Jan; 9(1):363-9. PubMed ID: 12538489 [TBL] [Abstract][Full Text] [Related]
13. Intravesical instillation of doxorubicin hydrochloride and its incorporation into bladder tumors. Nakada T; Akiya T; Yoshikawa M; Koike H; Kayayama T J Urol; 1985 Jul; 134(1):54-7. PubMed ID: 4009823 [TBL] [Abstract][Full Text] [Related]
14. Dimethylsulfoxide enhances the absorption of chemotherapeutic drug instilled into the bladder. Hashimoto H; Tokunaka S; Sasaki M; Nishihara M; Yachiku S Urol Res; 1992; 20(3):233-6. PubMed ID: 1615585 [TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420 [TBL] [Abstract][Full Text] [Related]
16. The effect of verapamil on a multi-drug resistant bladder carcinoma cell line and its potential as an intravesical chemotherapeutic agent. Long JP; Prout GR; Wong YK; Lin CW J Urol; 1990 May; 143(5):1053-6. PubMed ID: 2329596 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
18. Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer. Lu S; Xu L; Kang ET; Mahendran R; Chiong E; Neoh KG Eur J Pharm Sci; 2016 Mar; 84():103-15. PubMed ID: 26780592 [TBL] [Abstract][Full Text] [Related]
19. Effect of intravesical instillation of antitumor drugs in the development of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumors in rats. Suzuki T; Imai K; Takezawa Y; Tsuji H; Yamanaka H; Suzuki K Hinyokika Kiyo; 1989 Feb; 35(2):247-51. PubMed ID: 2735235 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladder. Arentsen HC; Jansen CF; Hulsbergen-van de Kaa CA; Laihia JK; Pylkkänen L; Leino L; Oosterwijk E; Witjes JA J Urol; 2012 Apr; 187(4):1445-9. PubMed ID: 22341270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]